A detailed history of Parallel Advisors, LLC transactions in Grifols Sa stock. As of the latest transaction made, Parallel Advisors, LLC holds 804 shares of GRFS stock, worth $7,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
804
Previous 688 16.86%
Holding current value
$7,613
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.28 - $9.38 $728 - $1,088
116 Added 16.86%
804 $7,000
Q2 2024

Aug 08, 2024

SELL
$6.27 - $7.7 $5,743 - $7,053
-916 Reduced 57.11%
688 $4,000
Q1 2024

May 06, 2024

SELL
$5.47 - $11.38 $2,926 - $6,088
-535 Reduced 25.01%
1,604 $10,000
Q4 2023

Feb 09, 2024

BUY
$7.71 - $11.56 $6,730 - $10,091
873 Added 68.96%
2,139 $24,000
Q3 2023

May 20, 2024

BUY
$8.91 - $10.91 $115 - $141
13 Added 1.04%
1,266 $11,000
Q3 2023

Nov 13, 2023

BUY
$8.91 - $10.91 $115 - $141
13 Added 1.04%
1,266 $11,000
Q2 2023

May 20, 2024

BUY
$7.14 - $9.29 $49 - $65
7 Added 0.56%
1,253 $11,000
Q2 2023

Aug 04, 2023

BUY
$7.14 - $9.29 $49 - $65
7 Added 0.56%
1,253 $11,000
Q1 2023

May 20, 2024

SELL
$6.65 - $10.69 $2,380 - $3,827
-358 Reduced 22.32%
1,246 $9,000
Q1 2023

Apr 25, 2023

SELL
$6.65 - $10.69 $232 - $374
-35 Reduced 2.73%
1,246 $9,000
Q4 2022

Feb 03, 2023

SELL
$5.96 - $8.53 $12,378 - $17,716
-2,077 Reduced 61.85%
1,281 $10,000
Q3 2022

Nov 10, 2022

SELL
$5.95 - $14.3 $3,266 - $7,850
-549 Reduced 14.05%
3,358 $21,000
Q2 2022

Aug 01, 2022

BUY
$10.6 - $13.28 $3,476 - $4,355
328 Added 9.16%
3,907 $46,000
Q1 2022

Apr 28, 2022

SELL
$10.37 - $12.73 $8,098 - $9,942
-781 Reduced 17.91%
3,579 $42,000
Q4 2021

Jan 20, 2022

BUY
$10.21 - $15.27 $38,226 - $57,170
3,744 Added 607.79%
4,360 $49,000
Q3 2021

Nov 02, 2021

BUY
$14.07 - $17.3 $4,221 - $5,190
300 Added 94.94%
616 $9,000
Q2 2021

Aug 06, 2021

BUY
$16.62 - $18.94 $2,542 - $2,897
153 Added 93.87%
316 $5,000
Q1 2021

Apr 23, 2021

SELL
$15.15 - $19.78 $6,953 - $9,079
-459 Reduced 73.79%
163 $3,000
Q4 2020

Feb 02, 2021

BUY
$16.86 - $19.67 $3,962 - $4,622
235 Added 60.72%
622 $11,000
Q3 2020

Oct 27, 2020

BUY
$15.4 - $20.16 $3,249 - $4,253
211 Added 119.89%
387 $7,000
Q2 2020

Jul 16, 2020

SELL
$18.24 - $21.45 $8,408 - $9,888
-461 Reduced 72.37%
176 $3,000
Q1 2020

Apr 27, 2020

BUY
$16.28 - $25.63 $2,604 - $4,100
160 Added 33.54%
637 $12,000
Q4 2019

Jan 30, 2020

BUY
$19.57 - $23.52 $4,207 - $5,056
215 Added 82.06%
477 $11,000
Q3 2019

Nov 01, 2019

BUY
$19.85 - $22.76 $4,565 - $5,234
230 Added 718.75%
262 $5,000
Q2 2019

Aug 05, 2019

SELL
$17.59 - $21.1 $5,435 - $6,519
-309 Reduced 90.62%
32 $1,000
Q1 2019

May 01, 2019

BUY
$18.01 - $20.11 $6,141 - $6,857
341 New
341 $7,000
Q4 2018

Feb 05, 2019

SELL
$17.44 - $21.53 $226 - $279
-13 Closed
0 $0
Q1 2018

May 08, 2018

SELL
$20.31 - $24.95 $4,468 - $5,489
-220 Reduced 94.42%
13 $0
Q3 2017

Nov 15, 2017

BUY
$20.07 - $21.89 $4,676 - $5,100
233 New
233 $5,000
Q3 2017

Nov 14, 2017

SELL
$20.07 - $21.89 $4,134 - $4,509
-206 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
206
206 $4,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.43B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.